Study published on the relationship between imaging and OVA1® in assessing risk of ovarian cancer
3/24/2014
A new study of OVA1® clinical performance, titled "The Effect of Ovarian Imaging on the Clinical Interpretation of a Multivariate Index Assay," has been released as an online advance publication of The American Journal of Obstetrics & Gynecology.
Leukaemia caused by chromosome catastrophe
3/24/2014
Researchers have found that people born with a rare abnormality of their chromosomes have a 2,700-fold increased risk of a rare childhood leukaemia. In this abnormality, two specific chromosomes are fused together but become prone to catastrophic shattering.Acute lymphoblastic leukaemia, or ALL, is the most common childhood cancer.
Harms outweigh benefits for women aged 70 and over in national breast cancer screening programmes
3/24/2014
Extending national breast cancer screening programmes to women over the age of 70 does not result in a decrease in the numbers of cancers detected at advanced stages, according to new research from The Netherlands.
Lymphoma development and progression may be promoted by inhibition of CDK4
3/24/2014
Anticancer agents that target a cell-cycle regulatory protein to inhibit tumor growth might actually promote the development and progression of certain B-cell lymphomas, according to a new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).
About 6 percent of colorectal cancers are missed by colonoscopy
3/24/2014
About 6 percent of colorectal cancers are diagnosed within three to five years after the patient receives a clean colonoscopy report, according to a population-based study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah.
Preclinical study suggests HPV eradicated by AHCC supplement
3/24/2014
Treating cervical cancer cells with AHCC led to the eradication of HPV, human papillomavirus, as well as a decrease in the rate of tumor growth in-vitro and in-vivo, in research presented at the Society of Gynecological Oncology 45th Annual Meeting on Women's Cancer in Tampa, Florida. The study was led by Dr. Judith A. Smith, Pharm.D.
Major mechanism identified that drives kidney cancer progression
3/24/2014
The shortage of oxygen, or hypoxia, created when rapidly multiplying kidney cancer cells outgrow their local blood supply can accelerate tumor growth by causing a nuclear protein called SPOP - which normally suppresses tumor growth - to move out of the nucleus to the cytoplasm, where it has the opposite effect, promoting rapid proliferation.
A braking system for immune responses
3/24/2014
For the first time, researchers have identified a receptor on human cells that specifically recognizes crystals. It is found on immune cells and binds uric acid crystals, which trigger gout but also control immune responses. The team, led by researchers from Technische Universität München (TUM)'s Klinikum rechts der Isar hospital have published their findings in the Immunity journal.
More psychological support needed for breast cancer patients
3/24/2014
For women who are suffering from breast cancer, concern for their children is the greatest source of worry. A researcher at The Sahlgrenska Academy has shown this, and believes that women who are at the earliest stage of the treatment should be offered support by a psychologist or a social worker.One out of every ten women in Sweden is affected by breast cancer at some time in her life.
Breast cancer outcomes adversely affected by obesity and diabetes
3/24/2014
Both obesity and diabetes have adverse effects on outcomes in breast cancer patients who receive chemotherapy as primary treatment before surgery (neoadjuvant chemotherapy), according to research presented at the 9th European Breast Cancer Conference (EBCC-9).